CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON'S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA'S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES

Kevin McFarthing; Neha Prakash; Tanya Simuni

doi:10.3233/JPD-199001

CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON'S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA'S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES

Kevin McFarthing, Neha Prakash, Tanya Simuni

Neurology

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Original language	English (US)
Pages (from-to)	251-264
Number of pages	14
Journal	Journal of Parkinson's disease
Volume	9
Issue number	2
DOIs	https://doi.org/10.3233/JPD-199001
State	Published - Jan 1 2019

ASJC Scopus subject areas

Clinical Neurology
Cellular and Molecular Neuroscience

Access to Document

10.3233/JPD-199001

Cite this

@article{31f14acefd6b40b8a6060f7e62434c61,

title = "CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON'S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA'S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES",

author = "Kevin McFarthing and Neha Prakash and Tanya Simuni",

year = "2019",

month = jan,

day = "1",

doi = "10.3233/JPD-199001",

language = "English (US)",

volume = "9",

pages = "251--264",

journal = "Journal of Parkinson's disease",

issn = "1877-7171",

publisher = "IOS Press",

number = "2",

}

TY - JOUR

T1 - CLINICAL TRIAL HIGHLIGHTS

T2 - 1. GENE THERAPY FOR PARKINSON'S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA'S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES

AU - McFarthing, Kevin

AU - Prakash, Neha

AU - Simuni, Tanya

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85066947731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066947731&partnerID=8YFLogxK

U2 - 10.3233/JPD-199001

DO - 10.3233/JPD-199001

M3 - Article

C2 - 31127735

SN - 1877-7171

VL - 9

SP - 251

EP - 264

JO - Journal of Parkinson's disease

JF - Journal of Parkinson's disease

IS - 2

ER -

CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON'S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA'S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this